Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Amazon Great Indian Festival 2020 - Electronics

| More

Apollo Hospitals Enterprises - Recovering well from COVID-19 impact - ICICI Securities

Posted On: 2020-09-16 08:49:48

Apollo Hospitals Enterprises' (AHEL) Q1FY21 performance was impacted by lockdown across the country, however, pharmacy business remained strong cushioning COVID-19 impact on company's performance. Overall, revenues declined 15.6% YoY to Rs21.7bn due to 41.2% fall in the hospital business, although pharmacy business reported revenue growth of 21.0%. EBITDA margin (pre-Ind-AS 116 adjustment) stood at (2)%, down 1610bps YoY with significant drop in revenue. We expect performance to improve gradually in the coming quarters as occupancy level improves. We remain positive on AHEL's long-term outlook considering its strong brand and pan-India presence in the hospital segment, margin expansion also supported by cost control, and 13.5% EBITDA CAGR over FY20-FY23E. Maintain BUY.

- Revenue growth impacted by lockdown, expect gradual recovery: Hospitals business witnessed significant fall in revenue of 41.2% owing to reduced occupancy at 38% vs 66% YoY. This fall in occupancy was visible across the states post implementation of lockdown and postponement of elective surgeries by patients. The company's digital outreach for consultations and OPDs has supported growth. The occupancy level has risen gradually in Jul-Aug-Sep and Q2FY21 occupancy is expected to be above 50%. Pharmacy business continued to grow strong with revenues rising 21.0%. Addition of 284 new stores (YoY) to 3,780, and 11.9% increase in revenue per store to Rs3.4mn were the key triggers. We expect 300 store additions each year and 7.3% CAGR in revenue per store.

- Margins to recover but gradually: Hospital business margin stood at (12.7)% vs 17.8% YoY due to significant decline in sales. Gradual improvement in occupancy level (~50% currently) and various cost control exercises (human resource, administrative expenses etc.) undertaken by the company would help in gradual margin expansion. The consolidated margin (pre-Ind-AS 116) was negative in Q1FY21 and we expect positive margin Q2FY21 onwards. Overall, we estimate EBITDA margin to improve by 190bps over FY20-FY23E.

- Outlook: We expect the performance to improve in coming quarters supported by higher occupancy, cost control initiatives and continued growth momentum in pharmacy segment. We expect 8.8% revenue and 13.5% EBITDA CAGRs over FY20-FY23E. Minimal capex requirement in the near term would help generate FCF of ~Rs31bn over FY21E-FY23E which would help reduce leverage.

- Valuations: We lower FY21 revenue/EBITDA estimates by 5.5/26.1% to factor in lockdown impact and weak Q1FY21 but largely maintain FY22 estimates. Maintain BUY with a revised target price of Rs1,936/share based on SoTP valuation (earlier Rs1,666/share). Key downside risks are: higher competition in areas where AHEL has dominant position, prolonged lockdown and longer breakeven for newer hospitals.

Shares of APOLLO HOSPITALS ENTERPRISE LTD. was last trading in BSE at Rs.1688.9 as compared to the previous close of Rs. 1672.95. The total number of shares traded during the day was 78107 in over 5648 trades.

The stock hit an intraday high of Rs. 1738.65 and intraday low of 1678.95. The net turnover during the day was Rs. 133263189.

Source: Equity Bulls

Click here to send ur comments or to

Amazon Great Indian Festival 2020 - Mobiles

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Maintain ADD on L&T Infotech - Growth progression continues - HDFC Securities

Cipla Ltd - Launch of generic Nintedanib - Angel Broking

Britannia Industries Ltd - Q2 FY21 Result Update - YES Securities

Hindustan Unilever Ltd - Q2 FY21 Result Update - YES Securities

CCL Products Ltd - Q2 FY21 Result Update - YES Securities

Specialty chemicals - Price trend in Aug-20 - ICICI Securities

Hindustan Unilever - Willingness (necessity?) to sacrifice gross margins to drive growth - ICICI Securities

Britannia Industries - In-home consumption tailwind starts to taper-off - ICICI Securities

Balkrishna Industries - Quarter ends on a strong note - ICICI Securities

Refining & marketing - Diesel cracks: Light at the end of the tunnel? - ICICI Securities

Mahindra CIE Automotive - Resilient margin performance - ICICI Securities

Kajaria Ceramics - Q2FY21 Result Update - ICICI Securities

Hindustan Unilever - Q2FY21 Result Update - ICICI Securities

Castrol India - Initiating Coverage - Compelling Valuation & Counting on Dividend Support - Reliance Research

Reliance Research - R Long Short - Mahindra & Mahindra Financial Services : Directional Long

Kajaria Ceramics - Q2FY21 First Cut - ICICI Securities

Quant Pick - Larsen & Toubro - ICICI Securities

Hindustan Unilever - Q2FY21 First Cut - ICICI Securities

Hindustan Zinc - Q2FY21 First Cut - ICICI Securities

Dhanuka Agritech - Buy back - Angel Broking

Equitas SFB IPO - Day 1 Subscription - Angel Broking

Dr. Reddy's lab relaunch of OTC product - Angel Broking

Hindustan Unilever Ltd - Q2FY21 Results - Angel Broking

Hindustan Unilever Ltd - Q2FY21 Results - YES Securities

Maintain BUY on ACC - Strong cost controls cushion earnings - HDFC Securities

Equitas Small Finance Bank (ESFB) - Subscribe - YES Securities

Granules India - Q2FY2021 results - Angel Broking

Sunteck Realty - Acquisition of 50 acres - Angel Broking

Maintain BUY on Oberoi Realty - Sharp recovery - HDFC Securities

L&T bidding for rail corridor - Angel Broking

Maintain REDUCE on L&T Technology Services - Recovery priced in - HDFC Securities

India IT Services - Thematic - Rising 5G Adoption to Industrialize Digital Services & Connectivity - Reliance Securities

L&T Technology Services - Q2FY21 Result - Angel Broking

L&T Technology Services - 'Multiple' headwinds - ICICI Securities

HDFC Life Insurance Company - Recovery well on track post Covid-19 dip - ICICI Securities

ACC - Strong execution - third time in a row - ICICI Securities

Tata Communications - Keeping faith on sales funnel for revenue growth - ICICI Securities

Hatsun Agro Products - Healthy revenues; strong margins - ICICI Securities

Amber Enterprises Ltd - Business Update Call - YES Securities

Key Takeaways from Q2FY21 earnings call of Shoppers Stop - YES Securities

CSB Bank Q2 FY21 - Not Rated - YES Securities

Britannia Industries 2QFY21 results - YES Securities

HDFC Life Insurance - Q2FY21 Results - YES Securities

ACC Ltd - Q3CY20 Results - YES Securities

IPO Review - Equitas Small Finance Bank - ICICI Securities

Rallis India - Q2FY21 First Cut - ICICI Securities

ACC Ltd - Q3CY20 First Cut - ICICI Securities

Equitas Small Finance Bank Limited - Strongly developing from a microfinance to small bank... - Geojit

Britannia Industries - Q2FY21 Results - Angel Broking

Rallis India - Q2FY21 Results - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019